Drug developer ADARx seeks $1.74 billion valuation in US IPO – Reuters 📅 Published: September 21, 2026 | 📂 Category: English Drug developer ADARx seeks $1.74 billion valuation in US IPO Reuters 📱 Share on WhatsApp 🌐 View Original Article Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
